Domov › Rakovina prsníka › Arizona › Tucson
Klinické štúdie Rakovina prsníka v meste Tucson, AZ
20 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Tucson a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Prebieha náborFáza 3
- The University of Arizona Cancer Center - North Campus ( Site 0055), Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Prebieha náborFáza 2
- The University of Arizona Cancer Center - North Campus, Tucson
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Prebieha náborFáza 3
- University of Arizona Cancer Center ( Site 0035), Tucson
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Prebieha nábor
- University of Arizona Cancer Center, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- Arizona Clinical Research Center, Inc., Tucson
- University of Arizona Cancer Center, Tucson
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Prebieha náborFáza 1/2
- University of Arizona Cancer Center, Tucson
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Arizona, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Prebieha náborFáza 3
- University of Arizona-Cancer Center, Tucson
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Prebieha náborFáza 3
- Tucson Medical Center HealthCare, Tucson
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Prebieha náborFáza 1/2
- USOR Arizona Oncology Associates, Tucson
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Prebieha náborFáza 2
- University of Arizona Cancer Center - Prevention Research Clinic, Tucson
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Prebieha náborFáza 3
- University of Arizona - Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- The University of Arizona Cancer Center, Tucson
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Prebieha náborFáza 1
- The University of Arizona Cancer Center, Tucson
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Prebieha náborVítaní zdravých dobrovoľníkov
- University of Arizona, Tucson
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Prebieha náborObservačná štúdia
- Arizona Oncology Associates, PC - HOPE, Tucson
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Prebieha náborFáza 2
- Arizona Oncology Associates, Tucson
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
Prebieha nábor
- University of Arizona, Tucson
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Prebieha náborObservačná štúdia
- Arizona Oncology, Tucson
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Tucson
- Obézita18 štúdií
- Nemalobunkový karcinóm pľúc17 štúdií
- Nadváha15 štúdií
- Metastatická rakovina14 štúdií
- Rakovina (všetky typy)12 štúdií
- Kardiovaskulárne ochorenia12 štúdií
- Kolorektálny karcinóm11 štúdií
- Rakovina prostaty11 štúdií
- Diabetes mellitus 2. typu11 štúdií
- Steatotické ochorenie pečene10 štúdií
- Srdcové zlyhanie10 štúdií
- Vysoký krvný tlak10 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.